drugset / Trial / NCT04762316

Composition for Treating Uterine Fibroid (SB-UF)

NCT04762316

Phase 4 Completed 66 enrolled Trieu, Nguyen Thi, M.D.
RandomizedParallel-groupDouble-blindTreatment

Summary

Pregnenolone \& Pyridoxal Phosphate SB-UF for treating uterine fibroids in women's pregnancies to lose the size of fibroids and to dissolve fibroids. Uterine fibroids are a very common finding in women pregnancy of reproductive age, fibroids fast grow in the first trimester of pregnancy. SB-UF against the rapid growth of fibroids under the influence of hormones during pregnancy. Use SB-UF to think about regulating stable Oestrogen levels and dissolving fibroids. This is a substantial insight into disease pathogenesis, with a clear path toward clinical application, which would lead to a substantial advance and perfection in management or public health policy.

Timeline

Start
2019-01-01
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 10 mg
Subject Impatien balsamina extract Unknown 100 mg
Subject Pregnenolone Other / unclassified 60 mg
Subject Pyridoxal 5'-Phosphate Unknown 20 mg